B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Lentinan

300 PubMed studies analyzed ยท 11 RCTs ยท Evidence Score: 44.7

Research Domains

Lentinan has been studied across 20 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿ”ฌ Inflammation, ๐Ÿ›ก๏ธ Immunity, ๐Ÿซ Liver & Detox, ๐Ÿฆ  Gut & Microbiome. The primary research focus is ๐Ÿ”ฌ Oncology with 45% of studies addressing this area.

Loading evidence profile...

This evidence profile for Lentinan is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.